Related Experiment Video
Updated: Jun 5, 2026

09:03
Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR
Published on: May 29, 2014
Proteomics of human embryonic stem cells.
Chris S Hughes1, Amelia A Nuhn, Lynne M Postovit
1Don Rix Protein Identification Facility, Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.
Proteomics
|January 13, 2011
Summary
Human embryonic stem cells (hESCs) have self-renewal and pluripotent properties, making them valuable for regenerative medicine and disease research. Studying their proteome is crucial for understanding cellular processes and post-translational modifications.
Area of Science:
- Stem cell biology
- Proteomics
- Regenerative medicine
Background:
- Human embryonic stem cells (hESCs) are key for regenerative medicine, disease modeling, and drug discovery.
- hESCs possess self-renewal and pluripotency, enabling differentiation into over 200 cell types.
- Understanding protein expression and modifications in hESCs is vital for their therapeutic applications.
Purpose of the Study:
- To review recent proteomics analyses of hESCs.
- To highlight the importance of proteomic studies in understanding hESC biology.
- To connect proteomic findings to potential applications in medicine and research.
Main Methods:
- Review of published proteomics studies on hESCs.
- Analysis of protein expression profiles in hESCs.
- Investigation of post-translational modifications in hESC proteomes.
Main Results:
- Proteomics reveals critical insights into hESC function and differentiation.
- Post-translational modifications significantly impact hESC protein activity.
- Proteomic data complements transcriptomic data for a comprehensive understanding of hESCs.
Conclusions:
- Proteomics is essential for unlocking the full potential of hESCs in regenerative medicine.
- Further proteomic research will advance hESC applications in treating diseases like cancer, Alzheimer's, and Parkinson's.
- Understanding the hESC proteome is crucial for developing novel drug discovery and toxicity analysis models.
Related Concept Videos
Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

